These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2720052)

  • 21. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A measure of tumorigenic potency incorporating dose-response shape.
    Meier KL; Bailer AJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantile-function based null distribution in resampling based multiple testing.
    van der Laan MJ; Hubbard AE
    Stat Appl Genet Mol Biol; 2006; 5():Article14. PubMed ID: 17049025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian ranking of sites for engineering safety improvements: decision parameter, treatability concept, statistical criterion, and spatial dependence.
    Miaou SP; Song JJ
    Accid Anal Prev; 2005 Jul; 37(4):699-720. PubMed ID: 15949462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical Bayes screening of many p-values with applications to microarray studies.
    Datta S; Datta S
    Bioinformatics; 2005 May; 21(9):1987-94. PubMed ID: 15691856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modified Bonferroni method for discrete data.
    Tarone RE
    Biometrics; 1990 Jun; 46(2):515-22. PubMed ID: 2364136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tests of independence for bivariate survival data.
    Shih JH; Louis TA
    Biometrics; 1996 Dec; 52(4):1440-9. PubMed ID: 8962462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model-based time extrapolation for quantal response studies.
    Bailer AJ; Smith RJ
    Biometrics; 1994 Mar; 50(1):220-5. PubMed ID: 8086605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A graphical approach to sequentially rejective multiple test procedures.
    Bretz F; Maurer W; Brannath W; Posch M
    Stat Med; 2009 Feb; 28(4):586-604. PubMed ID: 19051220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An alternative approach to the analysis of animal carcinogenicity studies.
    Stallard N; Whitehead A
    Regul Toxicol Pharmacol; 1996 Jun; 23(3):244-8. PubMed ID: 8812967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing for a trend in tumor prevalence rates: I. Nonlethal tumors.
    Dinse GE
    Biometrics; 1985 Sep; 41(3):751-70. PubMed ID: 4074825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size calculation for multiple testing in microarray data analysis.
    Jung SH; Bang H; Young S
    Biostatistics; 2005 Jan; 6(1):157-69. PubMed ID: 15618534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical considerations and techniques for understanding physiological data, modeling, and treatments.
    Fitzpatrick BG
    Cardiovasc Eng; 2008 Jun; 8(2):135-43. PubMed ID: 18172762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly-k-trend tests for survival adjusted analysis of tumor rates formulated as approximate multiple contrast test.
    Schaarschmidt F; Sill M; Hothorn LA
    J Biopharm Stat; 2008; 18(5):934-48. PubMed ID: 18781526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of historical controls in time-adjusted trend tests for carcinogenicity.
    Ibrahim JG; Ryan LM
    Biometrics; 1996 Dec; 52(4):1478-85. PubMed ID: 8962464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regression analysis of multivariate interval-censored failure time data with application to tumorigenicity experiments.
    Tong X; Chen MH; Sun J
    Biom J; 2008 Jun; 50(3):364-74. PubMed ID: 18435503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple hypothesis testing to detect lineages under positive selection that affects only a few sites.
    Anisimova M; Yang Z
    Mol Biol Evol; 2007 May; 24(5):1219-28. PubMed ID: 17339634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.